Hookipa Pharma Inc Reports Results For The Quarter Ended In September: Earnings Summary

Hookipa Pharma

14/11/2022 14:31

* HOOKIPA Pharma Inc  HOOK.OQ  reported a quarterly adjusted
loss
of 25 cents​​ per share for the quarter ended in September. The
mean expectation of seven analysts for the quarter was for a
loss of 28 cents per share.
    * Revenue fell 42.4% to $2.23 million from a year ago;
analysts
expected $2.91 million. 
    * HOOKIPA Pharma Inc's reported EPS for the quarter was a
loss
of 25 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.2%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * HOOKIPA Pharma Inc shares had fallen by 6.7% this
quarter and
lost 46.4% so far this year.
    * The company reported a quarterly loss of $18.28 million.
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 02:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.28          -0.25          Beat
 Jun. 30 2022      -0.36          -0.23          Beat
 Mar. 31 2022      -0.24          -0.40          Missed
 Dec. 31 2021      -0.58          -0.65          Missed